Thrax Management’s Lam Research LRCX Stock Holding History

Thrax Management’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-424,580	Closed	-$3.57M	–	174
2016 Q2	$3.57M	Buy	+424,580	New	+$3.41M	0.55%	41

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Thrax Management's LRCX Position: Q3 2016 in Review

Thrax Management sold out of Lam Research (LRCX) in Q3 2016, closing a stake of 424,580 shares — an estimated $3.57M sold.

Thrax Management first reported a position in LRCX in Q2 2016 and held it in 1 quarter. The position peaked at $3.57M in Q2 2016. 605 funds tracked by Wall St. Rank hold LRCX as of Q3 2016.

Thrax Management reported no remaining Lam Research position as of Q3 2016 after selling out during the quarter.
Thrax Management sold 424,580 Lam Research shares in Q3 2016, an estimated $3.57M.
Thrax Management first reported a position in Lam Research in Q2 2016 and held it in 1 quarter.
Thrax Management's Lam Research position peaked at $3.57M in Q2 2016.
605 funds tracked by Wall St. Rank held Lam Research as of Q3 2016.

Based on Thrax Management's 13F filing for Q3 2016, filed 14 Nov 2016.